Wolverine Trading
VBIV

Wolverine Trading’s VBI Vaccines, Inc. New Common Stock (Canada) VBIV Stock Holding History

Wolverine Trading’s Portfolio VBIV Stock Details VBIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Hold
0
– – – 6206
2023
Q3 		– Hold
0
– – – 6149
2022
Q1 		– Hold
0
– – – 7481
2021
Q4 		– Hold
0
– – – 7790
2021
Q3 		– Sell
-658
Closed -$73K – 7764
2021
Q2 		$73K Buy
658
+181
+38% +$17.6K ﹤0.01% 5517
2021
Q1 		$42K Sell
477
-204
-30% -$20.7K ﹤0.01% 5683
2020
Q4 		$62K Buy
+681
New +$58.1K ﹤0.01% 4576

Other funds holding VBIV

PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.3B AUM 33.54% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return